RNA interference in ocular indications

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9095504
SERIAL NO

13636748

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to ocular administration of sd-rxRNA and rxRNAori molecules.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PHIO PHARMACEUTICALS CORP257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cardia, James Franklin, US 28 1316
Kamens, Joanne Newton, US 34 2026
Khvorova, Anastasia Westborough, US 393 10160
Libertine, Lyn Framingham, US 10 421
Salomon, William Worcester, US 31 1852
Samarsky, Dmitry Westborough, US 40 1609
Woolf, Tod M Sudbury, US 60 3269

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 4, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00